National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed)
ID: 355297Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $400K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355297

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-026.html
Timeline
    Description

    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced a funding opportunity for the National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed). This program aims to promote research education activities that engage students from diverse and underrepresented backgrounds in cancer research experiences, spanning from middle school through undergraduate studies, with a focus on research experiences, curriculum development, and outreach efforts. The initiative is crucial for enhancing diversity in the biomedical and behavioral sciences, ultimately fostering a new generation of researchers in cancer-related fields. Eligible organizations, including higher education institutions and nonprofits, can apply for grants with a budget cap of $400,000 per year for up to five years, with applications due by September 28, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-026.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-CA-24-026-Full-Announcement.html
    RFA-CA-24-026.html
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced a funding opportunity for the National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed). This program aims to promote research education activities that foster diversity in the biomedical and behavioral sciences, particularly focusing on engaging students from underrepresented backgrounds in cancer research experiences from middle school through undergraduate studies. Key components of the program include research experiences, curriculum development, and outreach efforts aimed at enhancing science education and career motivation. Institutions are encouraged to create unique programs leveraging their research strengths and fostering student retention in biomedical research careers. The funding opportunity allows applications for new, renewal, and resubmission proposals with a budget cap of $400,000 per year for a maximum of five years. Eligible organizations include higher education institutions, nonprofits, and governmental entities. A recruitment plan for diverse participants and a strong evaluation strategy for gauging program impact are essential for applications, which may be submitted via the NIH ASSIST system by the specified deadlines.
    Similar Opportunities
    Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the "Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)," aimed at enhancing the training of a workforce to meet the nation’s biomedical and clinical research needs, particularly in cancer research. This program seeks applications that propose innovative educational activities, specifically hands-on cancer research experiences lasting 8 to 15 weeks, complemented by additional educational initiatives. With a funding ceiling of $300,000 per year for a project period of up to five years, the program encourages participation from underrepresented groups and aims to provide unique educational opportunities not covered by existing programs. Interested applicants can find more information and guidelines at the NIH website, with the application deadline set for January 25, 2026.
    Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering funding through the Cancer Research Education Grants Program, specifically for Curriculum or Methods Development under the R25 designation. This program aims to support innovative educational activities that enhance training in cancer research, focusing on projects that address the causes, diagnoses, prevention, treatment, and care of cancer patients and their families. The initiative is crucial for developing a skilled workforce to meet the nation's biomedical and clinical research needs. Eligible applicants include a diverse range of organizations, with a maximum funding amount of $150,000 per year for a project period of up to two years. Applications can be submitted starting December 25, 2023, with a closing date of January 7, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) to enhance education and training in cancer research. This program aims to support innovative educational activities that address various aspects of cancer, including its causes, prevention, treatment, and rehabilitation, with a focus on developing a skilled workforce to meet national biomedical research needs. Eligible applicants include a diverse range of institutions such as Historically Black Colleges and Universities, Hispanic-serving Institutions, and community-based organizations, with a maximum funding amount of $300,000 per year. Applications will be accepted starting December 25, 2023, with recurring deadlines until January 2026, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced the "Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research" (R21 Clinical Trial Not Allowed). This funding opportunity aims to enhance diversity among early-stage and junior investigators in cancer research, particularly from groups that are underrepresented in the biomedical, behavioral, clinical, and social sciences. The initiative encourages innovative studies in cancer biology, with a maximum funding amount of $275,000 available over a two-year period, and applications must demonstrate scientific merit and innovation. The application window opens on May 17, 2024, with the first awards expected to be made in June 2024; interested applicants can find more information and submission guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    NICHD Research Education Programs (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) for Research Education Programs (R25), aimed at enhancing training for the biomedical, behavioral, and clinical research workforce. This grant supports innovative educational activities focused on research skills development, with a funding ceiling of $150,000 per year for a maximum of five years, and is not intended for clinical trials. The initiative emphasizes the importance of creating accessible educational opportunities that foster diversity and collaboration among participants, ranging from upper undergraduates to faculty. Interested applicants can find more information and application guidelines at the provided link, with proposals due by May 25, 2025, and inquiries directed to grantsinfo@nih.gov.
    NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R21 Clinical Trial Optional mechanism, aimed at supporting exploratory and developmental research in cancer diagnosis, treatment, imaging, symptom management, and prevention. This grant is designed to encourage innovative studies that challenge existing paradigms and address critical barriers in cancer research, particularly focusing on reducing disparities among underserved populations. Eligible applicants include a wide range of organizations, such as historically black colleges, tribal governments, and faith-based organizations, with a maximum funding amount of $275,000 available over a two-year period. Interested parties can find more information and application details at the provided link, with a submission deadline of July 1, 2025, and inquiries directed to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Mentored Research Scientist Development Award to Promote Diversity (K01), a federal grant aimed at enhancing diversity within the cancer research workforce. This funding opportunity supports individuals from underrepresented backgrounds in biomedical and clinical sciences by providing salary and research support for a period of 3 to 5 years under the mentorship of experienced researchers, specifically for projects that do not involve leading independent clinical trials. The initiative is crucial for addressing disparities in cancer incidence and mortality rates among underserved populations, fostering a diverse pool of research talent, and promoting innovative solutions to complex health challenges. Interested applicants must submit their proposals by November 12, 2024, and can find additional information and application guidelines at the NIH website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), is offering a funding opportunity titled "NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)" aimed at supporting innovative preclinical and early-phase clinical research in cancer diagnosis, treatment, and prevention. This grant, with a funding ceiling of $275,000 over two years, encourages exploratory studies that may involve significant risk but have the potential to lead to breakthroughs in cancer research, particularly for underserved populations. Applications will be evaluated based on their significance, innovation, and rigor, with key deadlines for submission set for January 2025. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Summer Research Education Experience Program (R25 Clinical Trial Not Allowed) aimed at enhancing educational activities in biomedical, behavioral, and clinical research. This program specifically targets high school and undergraduate students, as well as science teachers, providing them with hands-on research experiences during the summer academic break, while fostering diversity and inclusion in research. Applicants can request funding up to $125,000 per year, with proposals due by March 17, 2027, and are encouraged to align their programs with the specific mission areas of the participating NIH institutes. For further details, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-204.html.
    NCI Small Grants Program for Cancer Research (NCI Omnibus) (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the NCI Small Grants Program for Cancer Research (R03), aimed at supporting short-term cancer research projects that require limited resources. This funding opportunity encourages diverse research efforts, including pilot studies, secondary data analyses, and the development of research methodologies, with a maximum budget of $50,000 per year for projects lasting up to two years. The program is designed to address significant knowledge gaps in cancer research and is open to a wide range of applicants, including public, private, and foreign entities. Interested parties should note that the application period opens on January 24, 2025, with a submission deadline of February 24, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.